Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $108,080 | 23 | 59.1% |
| Long term medical supply or device loan | $72,000 | 15 | 39.4% |
| Food and Beverage | $2,230 | 42 | 1.2% |
| Gift | $475.00 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AngioDynamics, Inc. | $180,424 | 43 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,093 | 23 | $0 (2020) |
| Boston Scientific Corporation | $573.04 | 10 | $0 (2024) |
| Allergan Inc. | $491.38 | 4 | $0 (2017) |
| Medtronic, Inc. | $203.33 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24,242 | 8 | AngioDynamics, Inc. ($24,000) |
| 2023 | $24,204 | 7 | AngioDynamics, Inc. ($24,000) |
| 2022 | $24,104 | 9 | AngioDynamics, Inc. ($24,000) |
| 2021 | $24,260 | 10 | AngioDynamics, Inc. ($24,033) |
| 2020 | $24,124 | 10 | AngioDynamics, Inc. ($24,017) |
| 2019 | $24,212 | 8 | AngioDynamics, Inc. ($24,026) |
| 2018 | $19,766 | 18 | AngioDynamics, Inc. ($19,307) |
| 2017 | $17,874 | 13 | AngioDynamics, Inc. ($17,042) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2024 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2024 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2024 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2024 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 08/07/2024 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Varithena_PI | ||||||
| 04/06/2024 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $172.59 | General |
| Category: Varithena_PI | ||||||
| 02/12/2024 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $44.99 | General |
| Category: Varithena_PI | ||||||
| 12/31/2023 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2023 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2023 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2023 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2023 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/14/2023 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $180.14 | General |
| Category: Varithena_PI | ||||||
| 08/23/2023 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Varithena_PI | ||||||
| 12/31/2022 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2022 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2022 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2022 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2022 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/13/2022 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Varithena_PI | ||||||
| 10/05/2022 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: Varithena_PI | ||||||
| 06/01/2022 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $37.53 | General |
| Category: Varithena_PI | ||||||
| 03/18/2022 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Varithena_PI | ||||||
| 12/31/2021 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Education | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 2,964 | 4,057 | $6.6M | $2.9M |
| 2022 | 12 | 3,319 | 5,076 | $6.8M | $3.0M |
| 2021 | 11 | 3,510 | 5,474 | $6.4M | $3.2M |
| 2020 | 12 | 3,224 | 6,101 | $7.2M | $3.0M |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36482 | Chemical destruction of first incompetent vein of arm or leg using imaging guidance | Office | 2023 | 451 | 751 | $2.3M | $1.2M | 52.9% |
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2023 | 351 | 598 | $1.6M | $745,132 | 46.1% |
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2023 | 387 | 679 | $2.0M | $679,679 | 33.4% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 801 | 885 | $354,000 | $133,911 | 37.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 429 | 429 | $128,700 | $41,912 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 413 | 462 | $92,400 | $36,687 | 39.7% |
| 36471 | Injection of chemical agent into multiple incompetent veins of leg | Office | 2023 | 39 | 146 | $61,539 | $24,433 | 39.7% |
| 36466 | Injection of chemical agent into multiple incompetent veins of same leg using ultrasound guidance | Office | 2023 | 18 | 18 | $63,000 | $24,146 | 38.3% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 37 | 44 | $13,200 | $4,729 | 35.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 38 | 45 | $6,273 | $2,175 | 34.7% |
| 36482 | Chemical destruction of first incompetent vein of arm or leg using imaging guidance | Office | 2022 | 402 | 733 | $2.2M | $1.2M | 54.6% |
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2022 | 374 | 689 | $2.1M | $715,206 | 34.6% |
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2022 | 307 | 543 | $1.5M | $698,990 | 47.7% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2022 | 840 | 1,012 | $404,800 | $154,134 | 38.1% |
| 36466 | Injection of chemical agent into multiple incompetent veins of same leg using ultrasound guidance | Office | 2022 | 42 | 48 | $168,000 | $68,195 | 40.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 460 | 460 | $138,000 | $44,599 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 470 | 557 | $111,400 | $44,092 | 39.6% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2022 | 180 | 358 | $107,400 | $40,421 | 37.6% |
| 36471 | Injection of chemical agent into multiple incompetent veins of leg | Office | 2022 | 35 | 127 | $53,531 | $22,214 | 41.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 179 | 359 | $50,048 | $17,960 | 35.9% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 15 | 72 | $16,272 | $7,777 | 47.8% |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 2022 | 15 | 118 | $31,580 | $6,896 | 21.8% |
| 36482 | Chemical destruction of incompetent vein of arm or leg, accessed through the skin using imaging guidance | Office | 2021 | 354 | 656 | $2.0M | $1.2M | 60.0% |
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2021 | 361 | 692 | $1.9M | $990,733 | 53.0% |
| 36475 | Destruction of insufficient vein of arm or leg, accessed through the skin | Office | 2021 | 255 | 432 | $1.3M | $518,366 | 40.0% |
About Dr. Sam Ebrahimi, MD
Dr. Sam Ebrahimi, MD is a Vascular Surgery healthcare provider based in Tarzana, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1114916376.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sam Ebrahimi, MD has received a total of $182,785 in payments from pharmaceutical and medical device companies, with $24,242 received in 2024. These payments were reported across 83 transactions from 5 companies. The most common payment nature is "Education" ($108,080).
As a Medicare-enrolled provider, Ebrahimi has provided services to 13,017 Medicare beneficiaries, totaling 20,708 services with total Medicare billing of $12.1M. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Vascular Surgery
- Other Specialties Vascular Surgery, Vascular Surgery
- Location Tarzana, CA
- Active Since 10/19/2005
- Last Updated 10/23/2016
- Taxonomy Code 2086S0129X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114916376
Products in Payments
- VenaCure 1470 Pro (Device) $96,033
- EVLT (Device) $84,080
- ClosureFast (Device) $591.66
- Varithena Administration Pack (Device) $549.42
- VenaSeal (Device) $535.04
- Ellipsys (Device) $169.27
- GENERAL VASCULAR INTERVENTION (Device) $23.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.